European Long-acting Antipsychotics in Schizofrenia Trial EULAST

Trial Profile

European Long-acting Antipsychotics in Schizofrenia Trial EULAST

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2017

At a glance

  • Drugs Aripiprazole (Primary) ; Paliperidone (Primary) ; Aripiprazole; Paliperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms EULAST
  • Most Recent Events

    • 04 Sep 2017 Planned End Date changed from 1 Aug 2018 to 1 Jan 2020.
    • 04 Sep 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jul 2018.
    • 11 May 2017 This trial has been discontinued in Netherlands as per European Clinical Trial Database record (EudraCT2014-002765-30)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top